[March 15, 2018]

North American Clinical Chemistry Reagents & Analyzers Market Report 2021: Supplier Shares & Strategies, Volume & Sales Segment Forecasts, Technology and Instrumentation Review - ResearchAndMarkets.com

The "North America Clinical Chemistry Reagents and Analyzers Market 2021: USA, Canada, Mexico-Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review" report has been added to ResearchAndMarkets.com's offering.

This report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both centralized (hospitals, commercial laboratories), and POC/decentralized locations.

The report explores future market trends; forecasts specimen, test and sales volume; estimates sales and market shares of key suppliers in major countries; compares features of leading analyzers; profiles key competitors; and identifies specific product and marketing opportunities for reagent and instrument suppliers.

Clinical chemistry and immunodiagnostic markets are undergoing significant transformation, caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition.

Some segments, like routine chemistry, are already resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace creates exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, and calibrators.

Country Analyses

• Canada, Mexico, USA

• Estimates of facilities performing clinical chemistry and immunodiagnostic tests in major countries
• Test volume and sales projections

Market Segmentation Analysis

• Comprehensive review of the market dynamics, trends, structure, size, growth, and key suppliers
• Test volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays

Individual Tests Analyzed in the Report

• Clinical Chemistry
• Therapeutic Drug Monitoring (TDM)
• Endocrine Function
• Tumor Markers and Special Chemistry
• Immunoproteins
• Drugs of Abuse

Current and Emerging Products

• Analysis of current and emerging clinical chemistry and immunodiagnostic tests
• Review of current instrumentation technologies, and feature comparison of high-, medium-, and low-volume/POC analyzers

Technology Review

• Assessment of current and emerging technologies, and their potential market applications
• Companies developing or marketing new technologies and products by test

Strategic Recommendations

• New product development opportunities with significant market appeal
• Alternative market penetration strategies
• Potential market entry barriers and risks

Competitive Assessments

Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R&D:

• Abbott Laboratories
• AdnaGen/Alere
• Agilent Technologies (News - Alert)
• Bayer Healthcare
• Beckman Coulter/Danaher
• Biomedical Diagnostics
• BioMerieux
• Bio-Rad
• DiaSorin
• Eiken
• Fujirebio
• Grifols
• Instrumentation Laboratory
• Kyowa Medex
• Matritech/Alere
• Ortho-Clinical Diagnostics
• Quest Diagnostics
• Roche
• Siemens (News - Alert)
• Sysmex
• Thermo Fisher
• Tosoh
• Wako
• Wallac/PE

For more information about this report visit https://www.researchandmarkets.com/research/vq5cxv/north_american?w=4

View source version on businesswire.com: http://www.businesswire.com/news/home/20180315006259/en/

[ Back To TMCnet.com's Homepage ]